WO2002026998A3 - Hydrolases - Google Patents
Hydrolases Download PDFInfo
- Publication number
- WO2002026998A3 WO2002026998A3 PCT/US2001/030310 US0130310W WO0226998A3 WO 2002026998 A3 WO2002026998 A3 WO 2002026998A3 US 0130310 W US0130310 W US 0130310W WO 0226998 A3 WO0226998 A3 WO 0226998A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hydr
- hydrolases
- provides
- polynucleotides
- agonists
- Prior art date
Links
- 102000004157 Hydrolases Human genes 0.000 title abstract 5
- 108090000604 Hydrolases Proteins 0.000 title abstract 5
- 230000001594 aberrant effect Effects 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Neurosurgery (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Biotechnology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/382,000 US20040072190A1 (en) | 2001-09-28 | 2001-09-28 | Hydrolases |
CA002423953A CA2423953A1 (fr) | 2000-09-29 | 2001-09-28 | Hydrolases |
AU2001294823A AU2001294823A1 (en) | 2000-09-29 | 2001-09-28 | Hydrolases |
JP2002530761A JP2004524815A (ja) | 2000-09-29 | 2001-09-28 | ヒドロラーゼ |
EP01975504A EP1341921A2 (fr) | 2000-09-29 | 2001-09-28 | Hydrolases |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23709300P | 2000-09-29 | 2000-09-29 | |
US60/237,093 | 2000-09-29 | ||
US23837000P | 2000-10-06 | 2000-10-06 | |
US60/238,370 | 2000-10-06 | ||
US24128400P | 2000-10-17 | 2000-10-17 | |
US60/241,284 | 2000-10-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002026998A2 WO2002026998A2 (fr) | 2002-04-04 |
WO2002026998A3 true WO2002026998A3 (fr) | 2003-07-17 |
Family
ID=27398946
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/030310 WO2002026998A2 (fr) | 2000-09-29 | 2001-09-28 | Hydrolases |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1341921A2 (fr) |
JP (1) | JP2004524815A (fr) |
AU (1) | AU2001294823A1 (fr) |
CA (1) | CA2423953A1 (fr) |
WO (1) | WO2002026998A2 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001284902A1 (en) * | 2000-08-15 | 2002-02-25 | Zymogenetics Inc. | Human adenosine deaminase |
US6706513B2 (en) | 2000-08-21 | 2004-03-16 | Bristol-Myers Squibb Company | Adenosine deaminase homolog |
AU2001297575A1 (en) * | 2000-11-08 | 2002-10-08 | Millennium Pharmaceuticals, Inc. | 38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof |
MXPA05004677A (es) | 2002-10-31 | 2005-11-17 | Genentech Inc | Metodos y composiciones para aumentar la produccion de anticuerpos. |
CA3007908A1 (fr) | 2003-03-07 | 2005-04-14 | Dsm Ip Assets B.V. | Hydrolases, acides nucleiques les codant, et procedes de fabrication et d'utilisation correspondants |
US20080070291A1 (en) | 2004-06-16 | 2008-03-20 | David Lam | Compositions and Methods for Enzymatic Decolorization of Chlorophyll |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000028045A2 (fr) * | 1998-11-12 | 2000-05-18 | Incyte Pharmaceuticals, Inc. | Hydrolases humaines |
-
2001
- 2001-09-28 WO PCT/US2001/030310 patent/WO2002026998A2/fr not_active Application Discontinuation
- 2001-09-28 AU AU2001294823A patent/AU2001294823A1/en not_active Abandoned
- 2001-09-28 CA CA002423953A patent/CA2423953A1/fr not_active Abandoned
- 2001-09-28 JP JP2002530761A patent/JP2004524815A/ja active Pending
- 2001-09-28 EP EP01975504A patent/EP1341921A2/fr not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000028045A2 (fr) * | 1998-11-12 | 2000-05-18 | Incyte Pharmaceuticals, Inc. | Hydrolases humaines |
Non-Patent Citations (7)
Title |
---|
CHANG Z ET AL: "DEDUCED AMINO ACID SEQUENCE OF ESCHERICHIA-COLI ADENOSINE DEAMINASE REVEALS EVOLUTIONARILY CONSERVED AMINO ACID RESIDUES IMPLICATIONS FOR CATALYTIC FUNCTIONS", BIOCHEMISTRY, vol. 30, no. 8, 1991, pages 2273 - 2280, XP002210562, ISSN: 0006-2960 * |
DATABASE EMBL [online] EBI; 3 March 2000 (2000-03-03), NCI-CGAP: "gf44c04.x1 Soares testis NHT Homo sapiens cDNA clone", XP002210564, Database accession no. AI150008 * |
DATABASE EMBL [online] EBI; 8 June 2000 (2000-06-08), HEGDE P. ET AL.: "Assessment of gene expression patterns in a model of colon tumor metastasis using a 19200 element cDNA microarray", XP002210565, retrieved from EMBL Database accession no. AW964086 * |
HEGDE, P.ET AL.: "Identification of tumor markers in models of human colorectal cancer using a 19200-element complementary DNA microarray", CANCER RESEARCH, vol. 61, no. 21, 1 November 2001 (2001-11-01), pages 7792 - 7797, XP002210615 * |
HERSHFIELD M S ET AL: "Clinical expression, genetics and therapy of adenosine deaminase (ADA) deficiency.", JOURNAL OF INHERITED METABOLIC DISEASE, vol. 20, no. 2, 1997, pages 179 - 185, XP001097451, ISSN: 0141-8955 * |
MORISAKI T ET AL: "ADENYLATE DEAMINASE A MULTIGENE FAMILY IN HUMANS AND RATS", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 265, no. 20, 1990, pages 11482 - 11486, XP002210563, ISSN: 0021-9258 * |
VALENZUELA A ET AL: "HIV-1 envelope gp120 and viral particles block adenosine deaminase binding to human CD26.", ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY. UNITED STATES 1997, vol. 421, 1997, pages 185 - 192, XP001097454, ISSN: 0065-2598 * |
Also Published As
Publication number | Publication date |
---|---|
AU2001294823A1 (en) | 2002-04-08 |
JP2004524815A (ja) | 2004-08-19 |
CA2423953A1 (fr) | 2002-04-04 |
WO2002026998A2 (fr) | 2002-04-04 |
EP1341921A2 (fr) | 2003-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001098468A3 (fr) | Proteases | |
WO2001007628A3 (fr) | Synthetases humaines | |
WO2003052075A3 (fr) | Enzymes | |
WO2002008396A3 (fr) | Proteases | |
WO2001096547A3 (fr) | Kinases humaines | |
WO2001060991A3 (fr) | Kinases humaines | |
WO2002018557A3 (fr) | Kinases humaines | |
WO2001098354A3 (fr) | Recepteurs | |
WO2001051638A3 (fr) | Enzymes de metabolisation de medicaments | |
WO2001090334A3 (fr) | Enzymes de metabolisation de medicaments | |
WO2001072777A3 (fr) | Facteurs de transcription | |
WO2001046397A3 (fr) | Kinases humaines | |
WO2002004612A3 (fr) | Enzymes metabolisant les medicaments | |
WO2002038744A3 (fr) | Protéases | |
WO2003042357A3 (fr) | Enzymes | |
WO2002026950A3 (fr) | Transferases | |
WO2001096546A3 (fr) | Proteine-phosphatases | |
WO2001098471A8 (fr) | Phosphodiesterases | |
WO2001085942A3 (fr) | Proteines associees au cytosquelette | |
WO2001071004A3 (fr) | Proteases | |
WO2002010363A3 (fr) | Proteines phosphatases | |
WO2000042201A3 (fr) | Peptidases humaines | |
WO2002026998A3 (fr) | Hydrolases | |
WO2002020736A3 (fr) | Proteases | |
WO2002024924A3 (fr) | Proteine phosphatases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002530761 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2423953 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10382000 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001975504 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 2001975504 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001975504 Country of ref document: EP |